MedSci 2013年春节放假通知

2013-02-04 MedSci MedSci原创

尊敬的MedSci会员: 根据《国务院办公厅关于2013年部分节假日安排的通知》,为便于大家及早安排节假日事宜, MedSci2013年春节放假安排如下: 2月9日(星期六,农历除夕)至15日(星期五,农历正月初六)放假调休(红框标注),共7天。 2月16日(星期六)、2月17日(星期日)上班。具体如下: 放假期间,MedSci将不再安排相关客户服务支持等事宜,但仍然正常

尊敬的MedSci会员:
根据《国务院办公厅关于2013年部分节假日安排的通知》,为便于大家及早安排节假日事宜,
MedSci2013年春节放假安排如下:
2月9日(星期六,农历除夕)至15日(星期五,农历正月初六)放假调休(红框标注),共7天。
2月16日(星期六)、2月17日(星期日)上班。具体如下:



放假期间,MedSci将不再安排相关客户服务支持等事宜,但仍然正常接收邮件,请发送邮件至 editing@medsci.cn,我们将在上班后尽快处理,敬请大家理解。特此通知。
紧急联系人:
Peter:18616373622
衷心感谢大家对MedSci的支持与信任! 
我们将一如既往的专注于医学生物学领域,提供专业科研与临床学术服务。
祝大家在新的一年里万事如意!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=5481, encodeId=8851548139, content=9t9yuk67w, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123.151.39.41, createdTime=Tue Feb 26 18:14:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360229, encodeId=6d56136022984, content=<a href='/topic/show?id=54b25e316f9' target=_blank style='color:#2F92EE;'>#放假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57316, encryptionId=54b25e316f9, topicName=放假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385668, encodeId=a5a11385668be, content=<a href='/topic/show?id=526259e00c1' target=_blank style='color:#2F92EE;'>#春节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59700, encryptionId=526259e00c1, topicName=春节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc4b507, createdName=guozhenyu, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605896, encodeId=cd3b1605896eb, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2013-02-26 123.151.39.41

    9t9yuk67w

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=5481, encodeId=8851548139, content=9t9yuk67w, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123.151.39.41, createdTime=Tue Feb 26 18:14:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360229, encodeId=6d56136022984, content=<a href='/topic/show?id=54b25e316f9' target=_blank style='color:#2F92EE;'>#放假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57316, encryptionId=54b25e316f9, topicName=放假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385668, encodeId=a5a11385668be, content=<a href='/topic/show?id=526259e00c1' target=_blank style='color:#2F92EE;'>#春节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59700, encryptionId=526259e00c1, topicName=春节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc4b507, createdName=guozhenyu, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605896, encodeId=cd3b1605896eb, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2013-02-06 xinxin088
  3. [GetPortalCommentsPageByObjectIdResponse(id=5481, encodeId=8851548139, content=9t9yuk67w, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123.151.39.41, createdTime=Tue Feb 26 18:14:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360229, encodeId=6d56136022984, content=<a href='/topic/show?id=54b25e316f9' target=_blank style='color:#2F92EE;'>#放假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57316, encryptionId=54b25e316f9, topicName=放假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385668, encodeId=a5a11385668be, content=<a href='/topic/show?id=526259e00c1' target=_blank style='color:#2F92EE;'>#春节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59700, encryptionId=526259e00c1, topicName=春节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc4b507, createdName=guozhenyu, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605896, encodeId=cd3b1605896eb, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2013-02-06 guozhenyu
  4. [GetPortalCommentsPageByObjectIdResponse(id=5481, encodeId=8851548139, content=9t9yuk67w, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123.151.39.41, createdTime=Tue Feb 26 18:14:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360229, encodeId=6d56136022984, content=<a href='/topic/show?id=54b25e316f9' target=_blank style='color:#2F92EE;'>#放假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57316, encryptionId=54b25e316f9, topicName=放假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385668, encodeId=a5a11385668be, content=<a href='/topic/show?id=526259e00c1' target=_blank style='color:#2F92EE;'>#春节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59700, encryptionId=526259e00c1, topicName=春节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc4b507, createdName=guozhenyu, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605896, encodeId=cd3b1605896eb, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Feb 06 00:27:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]

相关资讯

对话SCI期刊主编——骨科高质量学术论著发表策略研讨会通知

尊敬的各位同仁: 近年骨科的发展非常迅速,脊柱、创伤、关节及骨科基础研究领域都不断涌现各种新理论和新技术,国内骨科经过几代人的努力,取得了有目共睹的巨大成就,研究与诊治水平正逐渐走向国际先进水平,但高质量临床研究的数量和优秀论著的发表数量仍具有很大的上升空间。

MedSci点评:2012年十大具有启示性的研究成果

Cell:硫利达嗪成功消灭人体白血病干细胞 MedSci点评:可能很多读者并不在意这一研究,因为有关肿瘤干细胞的研究实在太多了。但是这却是唯一从传统化学药物中发现具有靶向肿瘤干细胞的 药物,这为靶向肿瘤干细胞提供新的契机。虽然目前还不能找到所谓的肿瘤干细胞专属markers,但是从小分子中筛选有效药物,却是重要的途径。硫利达嗪可能为肿瘤干细胞靶向小分子药物提供一个思路,也值得深入探究其中的分子

MedSci祝您元旦快乐!

MedSci祝您元旦快乐!

MedSci 2013年元旦放假通知

尊敬的MedSci会员: 根据《国务院办公厅关于2013年部分节假日安排的通知》,为便于大家及早安排节假日事宜,MedSci 2013年元旦放假安排如下(红框内为放假期间): 在放假期间,MedSci将不再安排相关客户服务支持等事宜,但仍然正常接收邮件,请发送邮件至 editing@medsci.cn,我们将在上班后尽快处理,敬请大家理解。特此通知。 衷心感谢大家对Med

MedSci在2012个性化用药前沿研讨会发表主题演讲

受2012个性化用药前沿研讨会邀请,MedSci学术编辑朱大淼在会议上发表题为“CONSORT规范剖析与临床研究质量提升”主题演讲,受到广泛关注。本次会议由中国医师协会培训部主办,上海交通大学Bio-X研究院、复旦大学生物医学研究院联合主办,生物谷承办,中国科学院贺林院士担任大会主席,于2012年11月15日在上海召开,共有300余位专家出席。 朱博士演讲现场 朱博士从“临床研究为什么要遵

MedSci已开通微信 赶快加“MedSci”为好友吧!

从现在开始,大家可以在微信平台上与MedSci进行交流啦。 大家只需登录微信,通过以下两种方式即可加MedSci为好友,并获得MedSci推送的精彩内容,还可与MedSci聊天互动。 方法一:通过微信扫描下面的二维码: 方法二:点击“朋友们”->“添加好友”->“按号码查找”,输入2481198566,点击“查找”,添加即可。 MedSci将从每天所有发布的文章中,挑选出最